KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Chemed (CHE) Depreciation & Amortization - Total (2016 - 2026)

Chemed filings provide 18 years of Depreciation & Amortization - Total readings, the most recent being $14.3 million for Q1 2026.

  • For the quarter ending Q1 2026, Depreciation & Amortization - Total rose 6.38% year-over-year to $14.3 million, compared with a TTM value of $55.4 million through Mar 2026, up 4.51%, and an annual FY2025 reading of $54.6 million, up 3.2% over the prior year.
  • Depreciation & Amortization - Total hit $14.3 million in Q1 2026 for Chemed, up from $13.8 million in the prior quarter.
  • The five-year high for Depreciation & Amortization - Total was $14.3 million in Q1 2026, with the low at $12.1 million in Q4 2022.
  • Median Depreciation & Amortization - Total over the past 5 years was $13.1 million (2024), compared with a mean of $13.0 million.
  • The sharpest move saw Depreciation & Amortization - Total decreased 6.6% in 2022, then increased 8.15% in 2024.
  • Year by year, Depreciation & Amortization - Total stood at $12.1 million in 2022, then increased by 7.67% to $13.0 million in 2023, then rose by 1.84% to $13.3 million in 2024, then increased by 3.74% to $13.8 million in 2025, then rose by 3.95% to $14.3 million in 2026.
  • According to Business Quant data, Depreciation & Amortization - Total over the past three periods came in at $14.3 million, $13.8 million, and $13.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.